argenx SE (ARGX)
536.11
+11.53
(+2.20%)
USD |
NASDAQ |
Sep 27, 16:00
535.60
-0.51
(-0.10%)
After-Hours: 20:00
argenx Accounts Receivable (Quarterly): 515.96M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 515.96M |
December 31, 2023 | 417.99M |
June 30, 2023 | 304.23M |
December 31, 2022 | 241.23M |
June 30, 2022 | 112.39M |
December 31, 2021 | 28.06M |
June 30, 2021 | 12.05M |
December 31, 2020 | 0.287M |
June 30, 2020 | 9.628M |
December 31, 2019 | 25.37M |
June 30, 2019 | 0.1364M |
June 30, 2019 | 0.1364M |
December 31, 2018 | 0.2448M |
Date | Value |
---|---|
June 30, 2018 | 10.30M |
June 30, 2018 | 10.30M |
December 31, 2017 | 1.014M |
June 30, 2017 | 4.879M |
December 31, 2016 | 1.176M |
June 30, 2016 | 0.9722M |
December 31, 2015 | 0.7861M |
June 30, 2015 | 0.7425M |
December 31, 2014 | 0.9619M |
June 30, 2014 | 3.015M |
March 31, 2014 | 1.212M |
December 31, 2013 | 0.4005M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.287M
Minimum
Dec 2020
515.96M
Maximum
Jun 2024
166.72M
Average
70.22M
Median
Accounts Receivable (Quarterly) Benchmarks
NuCana PLC | -- |
DBV Technologies SA | -- |
Trinity Biotech PLC | 17.47M |
Adaptimmune Therapeutics PLC | 2.335M |
TC BioPharm (Holdings) PLC | -- |